Demasq, which has developed a knee imaging software engine (KIS) to help a clinician visualise the soft tissue of the knee joint using the original digital X-ray, has suspended its fund raising plans and its CE mark whilst it resolves certain technical issues. If these issues are resolved satisfactorily Demasq will then be in a position to revive its funding plans and CE mark and complete its independent studies to validate the product. At this time there can be no certainty that these issues will be resolved, and the company has made provision for half of its investment during the period. We will continue to monitor this investment closely.